Table 1.
Summary of characteristics of patients with confirmed COVID-19 and general dialysis population receiving dialysis at Emory Dialysis Facilities, March—May 2020
| Characterstics | Patients with confirmed COVID-19 n = 23 |
Emory Dialysis general populationa n = 751 |
|---|---|---|
| Median Age in years, (interquartile range) | 67.0 (63.2–70.3) | 59.0 (49–69) |
| Percent Female | 56.5% | 48.0% |
| Median BMI (interquartile range) | 27.3 (24.4–30.2) | 26.7 (22.8–32.6) |
| Race and Ethnicity | ||
| Black, Non-Hispanic | 78.3% | 87.2% |
| White, Hispanic | 13.0% | 2.1% |
| White, Non-Hispanic | 8.7% | 7.9% |
| Other | 0 | 2.8% |
| ESRD Etiology | ||
| Hypertension | 65.2% | 55.0% |
| Diabetes Mellitus | 21.7% | 18.9% |
| Dialysis Modality | ||
| In-center hemodialysis | 91.3% | 82.4% |
| Peritoneal dialysis | 8.7% | 16.0% |
| Comorbidities | ||
| Diabetes Mellitus | 56.5% | 52.5% |
| Hypertension | 82.6% | 78.9% |
| Cardiac disease | 43.5% | 48.8% |
| Pulmonary disease | 4.3% | 10.5% |
| On ACEI/ARB | 21.7% | 31.3% |
| Potential Exposures to COVID-19 | ||
| Household member with confirmed COVID-19 diagnosis | 17.4% | – |
| Nursing home resident | 47.8% | 4.9% |
| Outcome | ||
| Hospitalization | 82.6% | 8.2% |
| Death | 26.1% | – |
| Mean No. Days from Positive SARS-CoV-2 Test to Death (range)b | 16.8 (1–34.0) | – |
aEmory Dialysis general population includes all patients receiving dialysis care at Emory Dialysis including patients diagnosed with COVID-19 during the time period
bAmong 6 deaths